The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...
Rhode Island ranked second for its lung cancer survival rate, with more than 35% living five years post diagnosis. The state ...
December is Lung Cancer Awareness Month. With lung cancer being the number one cause of death among cancer diagnoses, it’s ...
The U.S. Preventative Task Force recommends a low-dose CT scan of the chest for anyone who is between ages 50 and 80 and has ...
The agency granted approval to durvalumab for the treatment of a subset of patients with limited-stage small cell lung cancer ...
Dr. Heba Ismail at Sutter Health’s California Pacific Medical Center has dedicated her career to the early detection and ...
The approval of durvalumab, based on data from the phase 3 ADRIATIC study, offers a new standard of care for patients with ...
Surge in lung cancer rates among non-smokers in India drives the need for better diagnostic tools: Dr Badiger: Shardul Nautiyal, Mumbai Thursday, December 5, 2024, 08:00 Hrs [IST] ...
The Tampa Bay Times e-Newspaper is a digital replica of the printed paper seven days a week that is available to read on ...
This page includes links to articles highlighting the top lung cancer research published on Cancer Therapy Advisor in 2024.
Cape Cod Healthcare will participate in a new national clinical research study focused on early detection of lung cancer with ...
Imfinzi was approved by the FDA for the treatment of adults with limited-stage small cell lung cancer without disease progression after chemotherapy and radiation.